|
US6183738B1
(en)
*
|
1997-05-12 |
2001-02-06 |
Phoenix Pharamacologics, Inc. |
Modified arginine deiminase
|
|
US6635462B1
(en)
*
|
1997-05-12 |
2003-10-21 |
Phoenix Pharmacologies, Inc. |
Mutated form of arginine deiminase
|
|
EP1337630A2
(en)
*
|
2000-11-28 |
2003-08-27 |
Phoenix Pharmacologics, Inc. |
Modified arginine deiminase
|
|
US6645739B2
(en)
*
|
2001-07-26 |
2003-11-11 |
Phoenix Pharmacologies, Inc. |
Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same
|
|
US8129330B2
(en)
|
2002-09-30 |
2012-03-06 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
|
US20040062748A1
(en)
*
|
2002-09-30 |
2004-04-01 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
|
CA2506244C
(en)
*
|
2002-11-18 |
2012-10-30 |
Phoenix Pharmacologics, Inc. |
Methods for inhibiting viral replication in vivo
|
|
FR2884717B1
(fr)
*
|
2005-04-25 |
2009-07-03 |
Erytech Pharma Soc Par Actions |
Erythrocytes renfermant de l'arginine deiminase
|
|
WO2007130453A2
(en)
|
2006-05-02 |
2007-11-15 |
Allozyne, Inc. |
Non-natural amino acid substituted polypeptides
|
|
US20080096819A1
(en)
*
|
2006-05-02 |
2008-04-24 |
Allozyne, Inc. |
Amino acid substituted molecules
|
|
FR2919804B1
(fr)
|
2007-08-08 |
2010-08-27 |
Erytech Pharma |
Composition et vaccin therapeutique anti-tumoral
|
|
CA2707840A1
(en)
*
|
2007-08-20 |
2009-02-26 |
Allozyne, Inc. |
Amino acid substituted molecules
|
|
JP2009044997A
(ja)
*
|
2007-08-20 |
2009-03-05 |
Sony Corp |
ビリルビンオキシダーゼ（ｂｏｄ）の被覆方法
|
|
EP2295560A1
(en)
|
2009-09-14 |
2011-03-16 |
RWTH Aachen University |
Directed evolution of arginine deiminase for increased activity at physiological pH
|
|
USRE48805E1
(en)
|
2013-03-06 |
2021-11-02 |
Vision Global Holdings Ltd. |
Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein
|
|
US9255262B2
(en)
*
|
2013-03-06 |
2016-02-09 |
Vision Global Holdings Ltd. |
Albumin-binding arginine deminase and the use thereof
|
|
EP3744341A1
(en)
|
2013-03-15 |
2020-12-02 |
TDW Group |
Arginine deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatment
|
|
KR102523031B1
(ko)
*
|
2014-03-18 |
2023-04-19 |
티디더블유 그룹 |
조작된 키메라성 페길화된 adi 및 사용 방법
|
|
AU2015317848B2
(en)
|
2014-09-16 |
2021-04-22 |
Polaris Group |
Arginine deiminase with reduced cross-reactivity toward ADI - PEG 20 antibodies for cancer treatment
|
|
US11613759B2
(en)
|
2015-09-04 |
2023-03-28 |
Sqz Biotechnologies Company |
Intracellular delivery of biomolecules to cells comprising a cell wall
|
|
JP7602702B2
(ja)
|
2016-05-03 |
2024-12-19 |
ステムセル テクノロジーズ カナダ インコーポレーテッド |
寛容性を誘導するための生体分子の細胞内送達
|
|
TWI847958B
(zh)
|
2016-07-05 |
2024-07-11 |
英屬開曼群島商北極星藥業集團股份有限公司 |
用精胺酸耗盡劑進行之組合癌症免疫療法
|
|
EP3534963B1
(en)
|
2016-11-02 |
2024-04-17 |
Polaris Group |
Formulations of pegylated arginine deiminase
|
|
CN116143678A
(zh)
|
2016-11-14 |
2023-05-23 |
杭州多禧生物科技有限公司 |
偶联连接体，含有此连接体的细胞结合分子-药物偶联物及其制备和应用
|
|
US12344645B2
(en)
|
2017-03-29 |
2025-07-01 |
Polaris Group |
Protein conjugates
|
|
WO2019042628A1
(en)
|
2017-08-31 |
2019-03-07 |
Erytech Pharma |
ARGININE DEIMINASE ENCAPSULATED WITHIN ERYTHROCYTES AND THEIR USE IN THE TREATMENT OF CANCER AND ARGINASE-1 DEFICIENCY
|
|
EP3449935A1
(en)
|
2017-08-31 |
2019-03-06 |
Erytech Pharma |
Arginine deiminase encapsulated inside erythrocytes and their use in treating cancer and arginase-1 deficiency
|
|
EP4007768A4
(en)
*
|
2019-08-01 |
2023-11-15 |
The University of North Carolina at Chapel Hill |
COMPOSITIONS AND METHODS FOR BINDING ANTIBODIES AND INHIBITING NEUTRALIZING ANTIBODIES
|
|
CA3128035A1
(en)
|
2020-08-13 |
2022-02-13 |
Bioasis Technologies, Inc. |
Combination therapies for delivery across the blood brain barrier
|
|
US20240309055A1
(en)
*
|
2021-02-03 |
2024-09-19 |
The University Of North Carolina At Chapel Hill |
Protein m analogs and fusion proteins and their use for inhibiting antibody function
|
|
WO2022078524A2
(en)
|
2021-11-03 |
2022-04-21 |
Hangzhou Dac Biotech Co., Ltd. |
Specific conjugation of an antibody
|